Our bet is not on Pfizer (but it is on this tiny firm)

Our intel suggests the firm that's 73X smaller than Pfizer will win the vaccine race You are receiving this as a part of your subscription to The Startup Investor. To remove your email from this list, [unsubscribe here](. [The Startup Investor] [You're Not Getting the Full Story on Pfizer...]( [Click to Watch Now]( Dear The Startup Investor Reader, Bob Keppel here with a serious message. I'm sure you've seen the news over the past week. Pfizer reported 90% COVID-19 vaccine effectiveness in their recent Phase III trial results. It is, undoubtedly, great news for the world. But it's only half the story. ([Full story here]( And although I want to see a vaccine just as much as you do, it's my obligation as Money Morning's publisher to tell you [the truth]( - especially when the mainstream media isn't. You may watch the news and think the vaccine is right around the corner, but the fact is this: - Pfizer's vaccine must be stored at -97 degrees Fahrenheit. There are currently ZERO medical facilities that can store it without expensive special equipment. - No one outside of Pfizer has actually seen the results. We do NOT know which patients were actually helped by the vaccine. - The vaccine remained effective only seven days after it was administered. It could wear off after a month, a year, or 10 years - no one knows. So if you ask me (or anyone on my team), our bet is NOT with Pfizer. [Instead, we're backing the tiny biotech firm developing what we call a "Super Vaccine."]( They plan to release their own results on their viable vaccine at the end of November. And based on [intel we've gathered]( they're about to blow Pfizer right out of the water. In fact, our team is projecting a [34,900% revenue surge to begin almost immediately]( after this announcement is made. Now, this company has not received the attention it deserves. More specifically, I have NOT seen it mentioned in any major headlines... yet. Which means, if you take my message seriously - an incredible opportunity has just presented itself. Even though the window is closing, you can still [secure a stake in this tiny vaccine company]( before their announcement. But make no mistake - this "Super Vaccine" is on the way. For folks who recognize the potential of [this tiny company]( the gains could be life-changing within the next year. [This presentation]( contains everything you need to know. Sincerely, Bob Keppel Publisher, The Startup Investor Please do not reply to this email. It was sent from an unmonitored mailbox. You are receiving this e-mail at {EMAIL}, as part of your subscription to The Startup Investor. To remove your email from this list: [unsubscribe here](. To cancel, or for any other questions or requests, please contact our Customer Service team: [Online]( Phone: 866-310-1498 (North America) 443-221-6766 (International) Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET. © 2020 Angels & Entrepreneurs. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201. [Website]( | [Privacy Policy]( | [Terms & Conditions](